Literature DB >> 33402344

Cyclin A2 localises in the cytoplasm at the S/G2 transition to activate PLK1.

Helena Silva Cascales1, Kamila Burdova2, Anna Middleton1, Vladislav Kuzin1, Erik Müllers1, Henriette Stoy1, Laura Baranello1, Libor Macurek2, Arne Lindqvist3.   

Abstract

Cyclin A2 is a key regulator of the cell cycle, implicated both in DNA replication and mitotic entry. Cyclin A2 participates in feedback loops that activate mitotic kinases in G2 phase, but why active Cyclin A2-CDK2 during the S phase does not trigger mitotic kinase activation remains unclear. Here, we describe a change in localisation of Cyclin A2 from being only nuclear to both nuclear and cytoplasmic at the S/G2 border. We find that Cyclin A2-CDK2 can activate the mitotic kinase PLK1 through phosphorylation of Bora, and that only cytoplasmic Cyclin A2 interacts with Bora and PLK1. Expression of predominately cytoplasmic Cyclin A2 or phospho-mimicking PLK1 T210D can partially rescue a G2 arrest caused by Cyclin A2 depletion. Cytoplasmic presence of Cyclin A2 is restricted by p21, in particular after DNA damage. Cyclin A2 chromatin association during DNA replication and additional mechanisms contribute to Cyclin A2 localisation change in the G2 phase. We find no evidence that such mechanisms involve G2 feedback loops and suggest that cytoplasmic appearance of Cyclin A2 at the S/G2 transition functions as a trigger for mitotic kinase activation.
© 2021 Silva Cascales et al.

Entities:  

Year:  2021        PMID: 33402344      PMCID: PMC7812317          DOI: 10.26508/lsa.202000980

Source DB:  PubMed          Journal:  Life Sci Alliance        ISSN: 2575-1077


  74 in total

1.  Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm.

Authors:  Mark Jackman; Yumiko Kubota; Nicole den Elzen; Anja Hagting; Jonathon Pines
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

2.  Assessing kinetics from fixed cells reveals activation of the mitotic entry network at the S/G2 transition.

Authors:  Karen Akopyan; Helena Silva Cascales; Elvira Hukasova; Adrian T Saurin; Erik Müllers; Himjyot Jaiswal; Danielle A A Hollman; Geert J P L Kops; René H Medema; Arne Lindqvist
Journal:  Mol Cell       Date:  2014-02-27       Impact factor: 17.970

3.  Transient activation of p53 in G2 phase is sufficient to induce senescence.

Authors:  Lenno Krenning; Femke M Feringa; Indra A Shaltiel; Jeroen van den Berg; René H Medema
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

4.  Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex.

Authors:  C Lukas; C S Sørensen; E Kramer; E Santoni-Rugiu; C Lindeneg; J M Peters; J Bartek; J Lukas
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

5.  Cyclin A2 is an RNA binding protein that controls Mre11 mRNA translation.

Authors:  Arun Kanakkanthara; Karthik B Jeganathan; Jazeel F Limzerwala; Darren J Baker; Masakazu Hamada; Hyun-Ja Nam; Willemijn H van Deursen; Naomi Hamada; Ryan M Naylor; Nicole A Becker; Brian A Davies; Janine H van Ree; Georges Mer; Virginia S Shapiro; L James Maher; David J Katzmann; Jan M van Deursen
Journal:  Science       Date:  2016-09-30       Impact factor: 47.728

6.  Cdk1 Phosphorylates SPAT-1/Bora to Promote Plk1 Activation in C. elegans and Human Cells.

Authors:  Yann Thomas; Luca Cirillo; Costanza Panbianco; Lisa Martino; Nicolas Tavernier; Françoise Schwager; Lucie Van Hove; Nicolas Joly; Anna Santamaria; Lionel Pintard; Monica Gotta
Journal:  Cell Rep       Date:  2016-04-07       Impact factor: 9.423

7.  The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing.

Authors:  Youngjo Kim; Natalia G Starostina; Edward T Kipreos
Journal:  Genes Dev       Date:  2008-09-15       Impact factor: 11.361

8.  Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements.

Authors:  Nawal Bendris; Bénédicte Lemmers; Jean-Marie Blanchard; Nikola Arsic
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

Review 9.  Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication.

Authors:  Claus Storgaard Sørensen; Randi G Syljuåsen
Journal:  Nucleic Acids Res       Date:  2011-09-21       Impact factor: 16.971

10.  Cdk1 phosphorylates SPAT-1/Bora to trigger PLK-1 activation and drive mitotic entry in C. elegans embryos.

Authors:  Nicolas Tavernier; Anna Noatynska; Costanza Panbianco; Lisa Martino; Lucie Van Hove; Françoise Schwager; Thibaut Léger; Monica Gotta; Lionel Pintard
Journal:  J Cell Biol       Date:  2015-03-09       Impact factor: 10.539

View more
  6 in total

1.  CCNB1 promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle.

Authors:  Min-Hua Rong; Jian-Di Li; Lu-Yang Zhong; Yu-Zhen Huang; Juan Chen; Li-Yuan Xie; Rong-Xing Qin; Xiao-Lian He; Zhan-Hui Zhu; Su-Ning Huang; Xian-Guo Zhou
Journal:  Exp Biol Med (Maywood)       Date:  2021-11-07

2.  The Apparent Requirement for Protein Synthesis during G2 Phase Is due to Checkpoint Activation.

Authors:  Sarah Lockhead; Alisa Moskaleva; Julia Kamenz; Yuxin Chen; Minjung Kang; Anay R Reddy; Silvia D M Santos; James E Ferrell
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

3.  Negative Modulation of the Angiogenic Cascade Induced by Allosteric Kinesin Eg5 Inhibitors in a Gastric Adenocarcinoma In Vitro Model.

Authors:  Alessia Ricci; Marialucia Gallorini; Donatella Del Bufalo; Amelia Cataldi; Ilaria D'Agostino; Simone Carradori; Susi Zara
Journal:  Molecules       Date:  2022-01-31       Impact factor: 4.411

4.  Zika Virus Induces Mitotic Catastrophe in Human Neural Progenitors by Triggering Unscheduled Mitotic Entry in the Presence of DNA Damage While Functionally Depleting Nuclear PNKP.

Authors:  Malgorzata Rychlowska; Abigail Agyapong; Michael Weinfeld; Luis M Schang
Journal:  J Virol       Date:  2022-04-12       Impact factor: 6.549

5.  Downregulation of the enhancer of zeste homolog 1 transcriptional factor predicts poor prognosis of triple-negative breast cancer patients.

Authors:  Wei Peng; Wei Tang; Jian-Di Li; Rong-Quan He; Jia-Yuan Luo; Zu-Xuan Chen; Jiang-Hui Zeng; Xiao-Hua Hu; Jin-Cai Zhong; Yang Li; Fu-Chao Ma; Tian-Yi Xie; Su-Ning Huang; Lian-Ying Ge
Journal:  PeerJ       Date:  2022-07-12       Impact factor: 3.061

6.  Aurora A kinase activation: Different means to different ends.

Authors:  Nicolas Tavernier; Frank Sicheri; Lionel Pintard
Journal:  J Cell Biol       Date:  2021-07-21       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.